Chemokine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
暂无分享,去创建一个
A. Mantovani | K. Matsushima | M. Thelen | R. Nibbs | A. Ben-Baruch | S. Sozzani | A. Zlotnik | R. Förster | G. Graham | M. Locati | A. Luster | I. Charo | J. Farber | R. Horuk | F. Bachelerie | C. Combadière | P. Murphy | H. Nomiyama | C. Power | M. Rosenkilde | A. Rot | O. Yoshie | A. Monaghan | J. Oppenheim | R. Hills | G. Moschovakis | Amanda E. I. Proudfoot | A. Mantovani
[1] R. Wong,et al. Comparison of the Potential Multiple Binding Modes of Bicyclam, Monocylam, and Noncyclam Small-Molecule CXC Chemokine Receptor 4 Inhibitors , 2008, Molecular Pharmacology.
[2] T. Boehm,et al. Three chemokine receptors cooperatively regulate homing of hematopoietic progenitors to the embryonic mouse thymus , 2011, Proceedings of the National Academy of Sciences.
[3] Soumaya Bennouna,et al. CXCR2 Deficiency Confers Impaired Neutrophil Recruitment and Increased Susceptibility During Toxoplasma gondii Infection1 , 2001, The Journal of Immunology.
[4] J. Strominger,et al. CD1d-Restricted NKT Cells Express a Chemokine Receptor Profile Indicative of Th1-Type Inflammatory Homing Cells 1 , 2003, The Journal of Immunology.
[5] B. Wiedenmann,et al. CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway. , 2004, Cytokine.
[6] R. Tracy,et al. The Duffy antigen receptor for chemokines regulates asthma pathophysiology , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[7] R. Abagyan,et al. Structural basis of ligand interaction with atypical chemokine receptor 3 , 2017, Nature Communications.
[8] V. Lougaris,et al. A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity , 2014, AIDS.
[9] D. Soler,et al. Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines , 2001, The Journal of Immunology.
[10] Robert N. Taylor,et al. Expression and regulation of CCR1 in peritoneal macrophages from women with and without endometriosis. , 2005, Fertility and sterility.
[11] B. Dewald,et al. N-terminal Peptides of Stromal Cell-derived Factor-1 with CXC Chemokine Receptor 4 Agonist and Antagonist Activities* , 1998, The Journal of Biological Chemistry.
[12] M. Baggiolini,et al. Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. , 1995, The Biochemical journal.
[13] D. Spandidos,et al. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. , 2007, Thrombosis research.
[14] M. Struthers,et al. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist. , 2010, Journal of immunological methods.
[15] P. Kloetzel,et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells , 2010, The Journal of experimental medicine.
[16] W. Teng,et al. CXCR4 antagonist AMD3100 ameliorates thyroid damage in autoimmune thyroiditis in NOD.H‑2h⁴ mice. , 2016, Molecular medicine reports.
[17] J. Sodroski,et al. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. , 1998, Cellular immunology.
[18] D. Postma,et al. Localization and Enhanced mRNA Expression of the Orphan Chemokine Receptor L-CCR in the Lung in a Murine Model of Ovalbumin-induced Airway Inflammation , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[19] S. Kunkel,et al. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] Ali Jazayeri,et al. Intracellular allosteric antagonism of the CCR9 receptor , 2016, Nature.
[21] Takayuki Itoh,et al. Microglia Express CCR5, CXCR4, and CCR3, but of These, CCR5 Is the Principal Coreceptor for Human Immunodeficiency Virus Type 1 Dementia Isolates , 1999, Journal of Virology.
[22] C. Mackay,et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.
[23] A. Quyyumi,et al. Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis , 2001, Circulation research.
[24] A. Baíllo,et al. EBI2 regulates CXCL13‐mediated responses by heterodimerization with CXCR5 , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] R. Gorlin,et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease , 2003, Nature Genetics.
[26] M. Röllinghoff,et al. Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis , 2007, Arthritis research & therapy.
[27] W. Green,et al. Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. , 2005, Histology and histopathology.
[28] C. Martínez-A,et al. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. , 2003, Blood.
[29] C. Dutertre,et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells , 2010, The Journal of experimental medicine.
[30] E. Wolf,et al. CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.
[31] J. Demartino,et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.
[32] A. Matsukawa,et al. Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[33] J. Broach,et al. A Point Mutation That Confers Constitutive Activity to CXCR4 Reveals That T140 Is an Inverse Agonist and That AMD3100 and ALX40-4C Are Weak Partial Agonists* , 2002, The Journal of Biological Chemistry.
[34] S. Treon,et al. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. , 2014, Blood.
[35] N. Hogg,et al. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. , 2011, Blood.
[36] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[37] H. Malling,et al. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. , 2000, Journal of immunology.
[38] Masahiko Kuroda,et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.
[39] P. Lipsky,et al. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue , 2007, Arthritis research & therapy.
[40] S. Stafford,et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. , 2000, Blood.
[41] Y. Kawakami,et al. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. , 1999, American journal of respiratory and critical care medicine.
[42] C. Mackay,et al. Discrete Steps in Binding and Signaling of Interleukin-8 with Its Receptor* , 1996, The Journal of Biological Chemistry.
[43] Y. Soda,et al. A CXC chemokine receptor, CXCR5/BLR1, is a novel and specific coreceptor for human immunodeficiency virus type 2. , 1999, Virology.
[44] P. Barnes,et al. Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. , 2002, American journal of respiratory and critical care medicine.
[45] T. Dobner,et al. Differentiation‐specific expression of a novel G protein‐coupled receptor from Burkitt's lymphoma , 1992, European journal of immunology.
[46] B. Moss,et al. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[48] D. Friend,et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] F. Goebel,et al. What’s New in HIV/AIDS? Chemokine Receptor Antagonists: A New Era of HIV Therapy? , 2005, Infection.
[50] G. Klein,et al. Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3 , 2002, Mammalian Genome.
[51] P. Scherle,et al. Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. , 2011, ACS medicinal chemistry letters.
[52] C. Chen,et al. A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain , 2017, Cell transplantation.
[53] H. Broxmeyer,et al. TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. , 1999, Blood.
[54] Jun Zhang,et al. Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1. , 2005, Cytokine.
[55] I. Charo,et al. In CCR2-/- mice monocyte recruitment and egress of LDL cholesterol in vivo is impaired. , 2003, Biochemical and biophysical research communications.
[56] F. Sellebjerg,et al. Chemokine receptor expression on B cells and effect of interferon-β in multiple sclerosis , 2002, Journal of Neuroimmunology.
[57] A. Clark,et al. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. , 1995, Biochemical and biophysical research communications.
[58] James J. Campbell,et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells , 1999, Nature.
[59] E. S. Baekkevold,et al. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue , 2002, Gut.
[60] Yu Wang,et al. Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK , 2000, The Journal of Immunology.
[61] M. Baba,et al. Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity. , 2006, Journal of medicinal chemistry.
[62] Jeffrey M. Smith,et al. Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection , 2014, The Journal of experimental medicine.
[63] Y. Takahama,et al. XCL1 and XCR1 in the immune system. , 2012, Microbes and infection.
[64] S. Durham,et al. CXCR1+CD4+ T Cells in Human Allergic Disease1 , 2004, The Journal of Immunology.
[65] B. Damaj,et al. Expression and regulation of chemokine receptors in human natural killer cells. , 2001, Blood.
[66] B. Rollins,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use only. , 2004 .
[67] Haihan Song,et al. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma , 2012, Molecular Biology Reports.
[68] R. Bravo,et al. Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor , 1997, The Journal of experimental medicine.
[69] N. Maeda,et al. Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. , 1999, Journal of immunology.
[70] Weiqi Wang,et al. Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.
[71] W. Streit,et al. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis , 1998, Journal of Neuroimmunology.
[72] R. Snyderman,et al. Role of the Cytoplasmic Tails of CXCR1 and CXCR2 in Mediating Leukocyte Migration, Activation, and Regulation1 , 2003, The Journal of Immunology.
[73] Richard J. Miller,et al. Regulation of calcium currents by chemokines and their receptors , 2002, Journal of Neuroimmunology.
[74] M. Baggiolini,et al. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. , 2000, Blood.
[75] G. Turcatti,et al. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5. , 2001, Journal of medicinal chemistry.
[76] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[77] F. Heppner,et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion , 2003, Nature.
[78] J. Serody,et al. C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. , 2005, Cancer research.
[79] T. Beaty,et al. Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans , 2003, Genes and Immunity.
[80] C. Adra,et al. Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics. , 2001, The European respiratory journal.
[81] B. Dave,et al. Autocrine Role of Interleukin-8 in Induction of Endothelial Cell Proliferation, Survival, Migration and MMP-2 Production and Angiogenesis , 2005, Angiogenesis.
[82] S. Narumiya,et al. The Chemokine Receptor CCR7 Activates in Dendritic Cells Two Signaling Modules That Independently Regulate Chemotaxis and Migratory Speed1 , 2005, The Journal of Immunology.
[83] D. Taub,et al. Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC Chemokine Receptor-1* , 2000, The Journal of Biological Chemistry.
[84] A. Martini,et al. Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis , 2005, Arthritis research & therapy.
[85] M. Baggiolini,et al. Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.
[86] I. Ghobrial,et al. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma. , 2004, Mayo Clinic proceedings.
[87] R. Catarino,et al. Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma. , 2005, Gynecologic oncology.
[88] 北川 清樹. Blockade of CCR2 ameliorates progressive fibrosis in kidney , 2004 .
[89] B. Daugherty,et al. The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states. , 2000, European journal of pharmacology.
[90] M. Takeuchi,et al. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines. , 2009, Bioorganic & medicinal chemistry.
[91] Yuetsu Tanaka,et al. A CCR2-V64I polymorphism affects stability of CCR2A isoform , 2004, AIDS.
[92] D. McDermott,et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.
[93] H. Kleinman,et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. , 1999, The American journal of pathology.
[94] R. Doms,et al. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains , 1996, Journal of virology.
[95] David E. Misek,et al. T Cell Chemokine Receptor Expression in Aging1 , 2003, The Journal of Immunology.
[96] A. Schuler,et al. Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2 , 2014, Journal of medicinal chemistry.
[97] H. Weiner,et al. Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.
[98] Ping Wang,et al. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization , 1998, Journal of cellular biochemistry.
[99] M. Pallardy,et al. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK. , 2004, The Journal of investigative dermatology.
[100] H. Nomiyama,et al. Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.
[101] Bernard Malissen,et al. Chemokine Receptor CCR9 Contributes to the Localization of Plasma Cells to the Small Intestine , 2004, The Journal of experimental medicine.
[102] Shoji Uehara,et al. A Role for CCR9 in T Lymphocyte Development and Migration1 , 2002, The Journal of Immunology.
[103] E. Kremmer,et al. Deficient CCR7 signaling promotes TH2 polarization and B‐cell activation in vivo , 2012, European journal of immunology.
[104] G. Graham,et al. Cutting Edge: Identification of the Orphan Receptor G-Protein-Coupled Receptor 2 as CCR10, a Specific Receptor for the Chemokine ESkine1 2 , 2000, The Journal of Immunology.
[105] J. Cyster,et al. Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.
[106] George Kolios,et al. The Chemokines CXCL9, CXCL10, and CXCL11 Differentially Stimulate Gαi-Independent Signaling and Actin Responses in Human Intestinal Myofibroblasts1 , 2005, The Journal of Immunology.
[107] E. Grove,et al. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[108] P. Schimmel,et al. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. , 1999, Science.
[109] K. Matsushima,et al. Pivotal role of CCL25 (TECK)-CCR9 in the formation of gut cryptopatches and consequent appearance of intestinal intraepithelial T lymphocytes. , 2002, International immunology.
[110] T. Schall,et al. CXCR7 Protein Is Not Expressed on Human or Mouse Leukocytes , 2010, The Journal of Immunology.
[111] Yolande Chvatchko,et al. A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock , 2000, The Journal of experimental medicine.
[112] H. Boddeke,et al. LPS‐induced expression of a novel chemokine receptor (L‐CCR) in mouse glial cells in vitro and in vivo , 2003, Glia.
[113] O. Wagner,et al. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome , 2005, Thrombosis and Haemostasis.
[114] M. Keating,et al. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. , 2007, Blood.
[115] S. Antoniu. Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma. , 2010, Current opinion in molecular therapeutics.
[116] J. Steyaert,et al. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non‐chemokine agonists , 2018, Biochemical pharmacology.
[117] P. Debré,et al. Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice , 2003, Circulation.
[118] W. Kuziel,et al. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. , 2005, Journal of immunology.
[119] T. Kipps,et al. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.
[120] A. Chevailler,et al. CCR7 is involved in the migration of neutrophils to lymph nodes. , 2011, Blood.
[121] M. Takiguchi,et al. Cutting Edge: Expression of Chemokine Receptor CXCR1 on Human Effector CD8+ T Cells1 , 2004, The Journal of Immunology.
[122] Á. Zaballos,et al. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3. , 1998, Journal of immunology.
[123] Ying Sun,et al. The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.
[124] B. Korber,et al. A new classification for HIV-1 , 1998, Nature.
[125] A. Luster,et al. Murine Monocyte Chemoattractant Protein (MCP)-5: A Novel CC Chemokine That Is a Structural and Functional Homologue of Human MCP-1 , 1997, The Journal of experimental medicine.
[126] J. Unitt,et al. Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists. , 2017, ACS medicinal chemistry letters.
[127] T. van der Poll,et al. CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. , 2001, The Journal of infectious diseases.
[128] A. Iellem,et al. Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells , 2001, The Journal of experimental medicine.
[129] Mónica Sala-Valdés,et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non‐Hodgkin lymphomas with widespread nodular dissemination , 2004, Journal of leukocyte biology.
[130] R. Bravo,et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. , 1998, Journal of immunology.
[131] Ji Ming Wang,et al. β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .
[132] Tong-Yuan Yang,et al. Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice , 2001, The Journal of experimental medicine.
[133] K. Mani,et al. Opposing Effects Mediated by the Chemokine Receptor CXCR2 on Myocardial Ischemia-Reperfusion Injury: Recruitment of Potentially Damaging Neutrophils and Direct Myocardial Protection , 2003, Circulation.
[134] B. Chandrasekar,et al. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. , 2004, The Journal of biological chemistry.
[135] P. Loetscher,et al. Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.
[136] C. J. Hutchings,et al. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors , 2017, Nature Reviews Drug Discovery.
[137] A. Richmond,et al. The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases To Mediate and Regulate Leukocyte Functions , 2012, The Journal of Immunology.
[138] H. Drexler,et al. Chemokine Receptor 7 Knockout Attenuates Atherosclerotic Plaque Development , 2010, Circulation.
[139] G. McFadden,et al. Evasion and exploitation of chemokines by viruses. , 1999, Cytokine & growth factor reviews.
[140] S. Sanders,et al. Functional Differences Between Monocyte Chemotactic Protein-1 Receptor A and Monocyte Chemotactic Protein-1 Receptor B Expressed in a Jurkat T Cell , 2000, The Journal of Immunology.
[141] Zahra Ahmadi,et al. An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis , 2016, Inflammation.
[142] K. Peden,et al. CCR9A and CCR9B: Two Receptors for the Chemokine CCL25/TECK/Ckβ-15 That Differ in Their Sensitivities to Ligand , 2000, The Journal of Immunology.
[143] Lixin Shao,et al. Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist. , 2011, ACS medicinal chemistry letters.
[144] F. Tacke,et al. Role of CCR8 and Other Chemokine Pathways in the Migration of Monocyte-derived Dendritic Cells to Lymph Nodes , 2004, The Journal of experimental medicine.
[145] L. Chieco‐Bianchi,et al. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene. , 1999, AIDS research and human retroviruses.
[146] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[147] M. Hutz,et al. High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[148] A. Magiera,et al. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation. , 2012, Blood.
[149] R. Ransohoff,et al. Induction of glial L‐CCR mRNA expression in spinal cord and brain in experimental autoimmune encephalomyelitis , 2004, Glia.
[150] G. Girolomoni,et al. CD56brightCD16– NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation , 2006, European journal of immunology.
[151] M. Augustus,et al. Cloning and characterization of a novel human chemokine receptor. , 1998, Biochemical and biophysical research communications.
[152] M. Hirsch,et al. Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1 , 2005, Antimicrobial Agents and Chemotherapy.
[153] J. Cyster,et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position , 2002, Nature.
[154] K. Tokunaga,et al. New variations of human CC-chemokine receptors CCR3 and CCR4 , 1999, Genes and Immunity.
[155] Kevin Wei,et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.
[156] Sanghamitra Bandyopadhyay,et al. Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. , 2005, Endocrinology.
[157] D. Steiner,et al. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. , 1997, DNA and cell biology.
[158] L. F. Kolakowski,et al. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. , 1994, The Journal of biological chemistry.
[159] E. Barksdale,et al. Murine neuroblastoma attenuates dendritic cell cysteine cysteine receptor 7 (CCR7) expression. , 2005, Journal of pediatric surgery.
[160] R. Doms,et al. Influence of the CCR2-V64I Polymorphism on Human Immunodeficiency Virus Type 1 Coreceptor Activity and on Chemokine Receptor Function of CCR2b, CCR3, CCR5, and CXCR4 , 1998, Journal of Virology.
[161] T. Bonner,et al. Brief Definitive Report Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309 , 2022 .
[162] A. Peled,et al. Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B‐cell acute lymphoblastic leukaemia , 2016, British journal of haematology.
[163] Aihua Li,et al. Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells. , 2002, Microvascular research.
[164] Y. Soda,et al. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection. , 1998, Biochemical and biophysical research communications.
[165] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[166] A. Proudfoot,et al. CCL18 Exhibits a Regulatory Role through Inhibition of Receptor and Glycosaminoglycan Binding , 2013, PloS one.
[167] W. Brück,et al. The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system , 2000, Journal of Neuroimmunology.
[168] D. Hua,et al. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer. , 2014, European review for medical and pharmacological sciences.
[169] B. Sipos,et al. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. , 2006, Cancer research.
[170] G. Nilsson,et al. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. , 2002, Biochemical and biophysical research communications.
[171] T. Kita,et al. Cell surface‐anchored SR‐PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6‐expressing cells , 2004, Journal of leukocyte biology.
[172] S. Targan,et al. The Role of Thymus-Expressed Chemokine and Its Receptor CCR9 on Lymphocytes in the Regional Specialization of the Mucosal Immune System1 , 2000, The Journal of Immunology.
[173] H. Sarau,et al. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function. , 1997, The Journal of pharmacology and experimental therapeutics.
[174] James J. Campbell,et al. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. , 2003, Blood.
[175] P. Young,et al. Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte Receptors , 1995, The Journal of Biological Chemistry.
[176] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[177] K. Matsushima,et al. The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B). , 1997, Journal of immunology.
[178] J. Curtis,et al. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. , 1999, The American journal of pathology.
[179] M. Abramson,et al. Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. , 2006, Journal of human genetics.
[180] J. Sodroski,et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.
[181] A. Zernecke,et al. Combinatorial Model of Chemokine Involvement in Glomerular Monocyte Recruitment: Role of CXC Chemokine Receptor 2 in Infiltration During Nephrotoxic Nephritis1 , 2001, The Journal of Immunology.
[182] T. Schall,et al. HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8 , 1999, The Journal of Biological Chemistry.
[183] P. Loetscher,et al. Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.
[184] A. Chuntharapai,et al. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. , 1994, Journal of immunology.
[185] C. Mackay,et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue , 2000, AIDS.
[186] A. Richmond,et al. Delayed wound healing in CXCR2 knockout mice. , 2000, The Journal of investigative dermatology.
[187] A. Zlotnik,et al. Recent advances in chemokines and chemokine receptors. , 1999, Critical reviews in immunology.
[188] O. Quehenberger,et al. Expression of Fractalkine (CX3CL1) and its Receptor, CX3CR1, Is Elevated in Coronary Artery Disease and Is Reduced During Statin Therapy , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[189] J. Van Damme,et al. Monocyte Chemoattractant Protein-3 Is a Functional Ligand for CC Chemokine Receptors 1 and 2B (*) , 1995, The Journal of Biological Chemistry.
[190] P. Scherle,et al. Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344 , 2005, The Journal of Immunology.
[191] O. Quehenberger,et al. Differential expression of the isoforms for the monocyte chemoattractant protein-1 receptor, CCR2, in monocytes. , 2002, Biochemical and biophysical research communications.
[192] A. Zlotnik,et al. Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1. , 2000, Biochemical and biophysical research communications.
[193] O. Yoshie,et al. Identification of Single C Motif-1/Lymphotactin Receptor XCR1* , 1998, The Journal of Biological Chemistry.
[194] S. Schulz,et al. CXCR4 Regulates Interneuron Migration in the Developing Neocortex , 2003, The Journal of Neuroscience.
[195] R. Appelberg,et al. The Involvement of the Chemokine Receptor CXCR2 in Neutrophil Recruitment in LPS‐Induced Inflammation and in Mycobacterium avium Infection , 2002, Scandinavian journal of immunology.
[196] P. Murphy,et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. , 2001, Blood.
[197] T. Meshel,et al. IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase. , 2003, Biochemistry.
[198] C. Garlanda,et al. Nonredundant role of CCRL2 in lung dendritic cell trafficking. , 2010, Blood.
[199] Hendrik Veelken,et al. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM‐B , 2010, Immunology.
[200] Q. Hamid,et al. The CCR3 Receptor Is Involved in Eosinophil Differentiation and Is Up-Regulated by Th2 Cytokines in CD34+ Progenitor Cells1 , 2003, The Journal of Immunology.
[201] Osamu Yoshie,et al. Cutting Edge: Profile of Chemokine Receptor Expression on Human Plasma Cells Accounts for Their Efficient Recruitment to Target Tissues 1 , 2003, The Journal of Immunology.
[202] P. Weller,et al. Extranuclear Lipid Bodies, Elicited by CCR3-mediated Signaling Pathways, Are the Sites of Chemokine-enhanced Leukotriene C4 Production in Eosinophils and Basophils* , 2001, The Journal of Biological Chemistry.
[203] Jason M. Edmonds,et al. Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model , 2013, Pharmaceutical Research.
[204] N. Ling,et al. The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19. , 2006, Biochemical and biophysical research communications.
[205] Y. Itoyama,et al. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients , 2005, Journal of Neuroimmunology.
[206] J. Mudgett,et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[207] A. Morgan,et al. Differential expression of CCR3 and CXCR3 by human lung and bone marrow‐derived mast cells: implications for tissue mast cell migration , 2005, Journal of leukocyte biology.
[208] T. Mcclanahan,et al. CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells , 1997, The Journal of experimental medicine.
[209] M. Baggiolini,et al. B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.
[210] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[211] C. Rouzioux,et al. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. , 1998, JAMA.
[212] F. Malavasi,et al. Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells. , 2002, International immunology.
[213] Kathleen M. Smith,et al. Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2)* , 2000, The Journal of Biological Chemistry.
[214] N. Klopp,et al. CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease , 2011, European Respiratory Journal.
[215] M. Capogrossi,et al. The chemokine receptor CCR8 mediates rescue from dexamethasone‐induced apoptosis via an ERK‐dependent pathway , 2003, Journal of leukocyte biology.
[216] C. Mackay,et al. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[217] J. Lillard,et al. Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[218] P. Allavena,et al. Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin , 2006, Transplantation.
[219] M. Lipp,et al. Signal Transduction by the Chemokine Receptor CXCR5: Structural Requirements for G Protein Activation Analyzed by Chimeric CXCR1/CXCR5 Molecules , 2001, Biological chemistry.
[220] J J Goedert,et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.
[221] Hualiang Jiang,et al. Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex , 2013, Science.
[222] Y. Hayashi,et al. CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. , 2006, Immunity.
[223] E. Meese,et al. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function , 1997, Current Biology.
[224] P. Gray,et al. Molecular Cloning and Functional Characterization of a Novel Human CC Chemokine Receptor (CCR5) for RANTES, MIP-1β, and MIP-1α* , 1996, The Journal of Biological Chemistry.
[225] E. Kriehuber,et al. Macrophage Inflammatory Protein 3α Is Involved in the Constitutive Trafficking of Epidermal Langerhans Cells , 1999, The Journal of experimental medicine.
[226] S. Keshav,et al. Clinical and Experimental Gastroenterology Dovepress Ccr9 Antagonism: Potential in the Treatment of Inflammatory Bowel Disease , 2022 .
[227] D. Petersen,et al. Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay , 2002, Human mutation.
[228] M. Rossi,et al. CCR5 Plays a Critical Role in the Development of Myocarditis and Host Protection in Mice Infected with Trypanosoma cruzi , 2005, The Journal of infectious diseases.
[229] Diederik F Van Wijk,et al. Genetic Association of the CCR5 Region With Lipid Levels in At-Risk Cardiovascular Patients , 2010, Circulation. Cardiovascular genetics.
[230] J. Crowe,et al. Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h , 2010, European journal of gastroenterology & hepatology.
[231] E. Grove,et al. The Chemokine Stromal Cell-Derived Factor-1 Regulates the Migration of Sensory Neuron Progenitors , 2005, The Journal of Neuroscience.
[232] Y. Xia,et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. , 1999, Kidney international.
[233] K. Krause,et al. Chemokine-induced cell death in CCR5-expressing neuroblastoma cells , 2003, Journal of Neuroimmunology.
[234] T. Kohout,et al. Differential Desensitization, Receptor Phosphorylation, β-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7* , 2004, Journal of Biological Chemistry.
[235] O. Yoshie,et al. Secondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7* , 1998, The Journal of Biological Chemistry.
[236] A. Roach,et al. Human vascular smooth muscle cells express receptors for CC chemokines. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[237] H. Kettenmann,et al. Secondary Lymphoid Tissue Chemokine (CCL21) Activates CXCR3 to Trigger a Cl− Current and Chemotaxis in Murine Microglia1 , 2002, The Journal of Immunology.
[238] K. Ley,et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[239] M. Mellado,et al. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics. , 2011, Blood.
[240] G. Barnea,et al. The genetic design of signaling cascades to record receptor activation , 2008, Proceedings of the National Academy of Sciences.
[241] P. Lipsky,et al. Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. , 2000, International immunology.
[242] A. Mantovani,et al. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.
[243] Richard P. Harvey,et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 , 2007, Proceedings of the National Academy of Sciences.
[244] D. Spandidos,et al. Significant involvement of CCR2–64I and CXCL12–3a in the development of sporadic breast cancer , 2004, Journal of Medical Genetics.
[245] K. Peden,et al. STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1 , 1997, The Journal of experimental medicine.
[246] C. Dunbar,et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. , 2006, Blood.
[247] R. Nibbs,et al. Immune regulation by atypical chemokine receptors , 2013, Nature Reviews Immunology.
[248] R. D'Agostino,et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. , 2003, The Journal of clinical investigation.
[249] W. Kuziel,et al. Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.
[250] Ruben Abagyan,et al. Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists , 2016, Nature.
[251] A. Rot,et al. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells , 2007, The Journal of experimental medicine.
[252] R. Förster,et al. Impaired responsiveness to T-cell receptor stimulation and defective negative selection of thymocytes in CCR7-deficient mice. , 2007, Blood.
[253] D. Littman,et al. Expression cloning of new receptors used by simian and human immunodeficiency viruses , 1997, Nature.
[254] Robert V Farese,et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.
[255] Yong Liu,et al. CCR7, CCR8, CCR9 and CCR10 in the mouse hippocampal CA1 area and the dentate gyrus during and after pilocarpine‐induced status epilepticus , 2007, Journal of neurochemistry.
[256] J. Flynn,et al. CCR5-Deficient Mice Control Mycobacterium tuberculosis Infection despite Increased Pulmonary Lymphocytic Infiltration1 , 2004, The Journal of Immunology.
[257] Q. Gao,et al. CCR7 enhances TGF-β1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer , 2015, Oncotarget.
[258] P. Proost,et al. Synergy between proinflammatory ligands of G protein‐coupled receptors in neutrophil activation and migration , 2004, Journal of leukocyte biology.
[259] E. Su,et al. Identification and expression of novel isoforms of human stromal cell-derived factor 1. , 2006, Gene.
[260] Alain Dupuy,et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. , 2005, Blood.
[261] R. Ransohoff,et al. Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion , 2002, Journal of neuroscience research.
[262] R. Zinkernagel,et al. CXCR5-Dependent Seeding of Follicular Niches by B and Th Cells Augments Antiviral B Cell Responses1 , 2005, The Journal of Immunology.
[263] Jun Yokota,et al. Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer. , 2015, Cancer research.
[264] S. Muruganandan,et al. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[265] I. González-Álvaro,et al. Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features , 2012, Arthritis Research & Therapy.
[266] M. Carson,et al. CCR7-Dependent Immunity during Acute Toxoplasma gondii Infection , 2010, Infection and Immunity.
[267] S. Heath,et al. A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients , 2007, Proceedings of the National Academy of Sciences.
[268] Simon A. Jones,et al. Chemokine Antagonists That Discriminate between Interleukin-8 Receptors , 1997, The Journal of Biological Chemistry.
[269] N. Mukaida,et al. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization , 2006, International journal of cancer.
[270] L. Ai,et al. Mutating the four extracellular cysteines in the chemokine receptor CCR6 reveals their differing roles in receptor trafficking, ligand binding, and signaling. , 2002, Biochemistry.
[271] H. Boddeke,et al. Expression of L‐CCR in HEK 293 cells reveals functional responses to CCL2, CCL5, CCL7, and CCL8 , 2003, Journal of leukocyte biology.
[272] Albert Zlotnik,et al. Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist , 2005, Journal of Pharmacology and Experimental Therapeutics.
[273] M. O. Baratti,et al. CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12 , 2014, PloS one.
[274] V. Malhotra,et al. CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis , 2013, Breast Cancer Research and Treatment.
[275] A. Akaike,et al. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? , 1998, FEBS letters.
[276] R. Förster,et al. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. , 2005, Blood.
[277] R. Förster,et al. CCR7 Essentially Contributes to the Homing of Plasmacytoid Dendritic Cells to Lymph Nodes under Steady-State As Well As Inflammatory Conditions , 2011, The Journal of Immunology.
[278] A. Ritchie,et al. Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. , 1999, Blood.
[279] J. Westwick,et al. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. , 1999, The Journal of clinical investigation.
[280] M. Nussenzweig,et al. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes. , 2001, Blood.
[281] J. Blackwell,et al. CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study , 2010, BMC Medical Genetics.
[282] C. Martínez-A,et al. Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs. , 2001, Blood.
[283] T. Schwartz,et al. The herpesvirus 8‐encoded chemokine vMIP‐II, but not the poxvirus‐encoded chemokine MC148, inhibits the CCR10 receptor , 2001, European journal of immunology.
[284] E. Génin,et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. , 2000, Science.
[285] Jason G. Cyster,et al. A chemokine-driven positive feedback loop organizes lymphoid follicles , 2000, Nature.
[286] T. Schwartz,et al. A Highly Selective CCR2 Chemokine Agonist Encoded by Human Herpesvirus 6* , 2003, The Journal of Biological Chemistry.
[287] R. Haas,et al. Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells. , 1997, Blood.
[288] M. Thelen,et al. The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes* , 2005, Journal of Biological Chemistry.
[289] D. Mucida,et al. Intraepithelial lymphocytes , 2017, Current Biology.
[290] Atsushi Mizoguchi,et al. Mice with a Selective Deletion of the CC Chemokine Receptors 5 or 2 Are Protected from Dextran Sodium Sulfate-Mediated Colitis: Lack of CC Chemokine Receptor 5 Expression Results in a NK1.1+ Lymphocyte-Associated Th2-Type Immune Response in the Intestine1 , 2000, The Journal of Immunology.
[291] D. S. van Ingen Schenau,et al. Early postnatal lethality and cardiovascular defects in CXCR7‐deficient mice , 2008, Genesis.
[292] M. Morganti-Kossmann,et al. Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[293] L. Rénia,et al. CCR5 deficiency decreases susceptibility to experimental cerebral malaria. , 2003, Blood.
[294] Xin Wang,et al. TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans , 2005, Antimicrobial Agents and Chemotherapy.
[295] Kazuhiko Yamamoto,et al. Chemokine receptors in human basophils: inducible expression of functional CXCR4 , 2001, Journal of leukocyte biology.
[296] F. Goebel,et al. CCR5 antagonists: a new tool in fighting HIV. , 2005, Journal of HIV therapy.
[297] J. Haines,et al. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis , 2000, Immunogenetics.
[298] Antal Rot,et al. CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.
[299] J. Christensen,et al. Efficient T-Cell Surveillance of the CNS Requires Expression of the CXC Chemokine Receptor 3 , 2004, The Journal of Neuroscience.
[300] L. Sibley,et al. Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis , 2005, The Journal of experimental medicine.
[301] B. Aronow,et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.
[302] S. Scala. Molecular Pathways: Targeting the CXCR4–CXCL12 Axis—Untapped Potential in the Tumor Microenvironment , 2015, Clinical Cancer Research.
[303] Simon A. Jones,et al. Granulocyte chemotactic protein 2 acts via both IL‐ 8 receptors, CXCR1 and CXCR2 , 1998, European journal of immunology.
[304] R. Terkeltaub,et al. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. , 2003, Journal of immunology.
[305] M. Baggiolini,et al. Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell‐derived factor 1α activation of Gi2 are differentially expressed in vivo , 1997, European journal of immunology.
[306] Á. Zaballos,et al. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP‐3α 1 , 1998 .
[307] M. Ratajczak,et al. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co‐receptor CXCR4 on their surface: determination of response to stromal‐derived factor‐1 by megakaryocytes and platelets , 1999, British journal of haematology.
[308] Yee‐Shin Lin,et al. Macrophage Migration Inhibitory Factor Triggers Chemotaxis of CD74+CXCR2+ NKT Cells in Chemically Induced IFN-γ–Mediated Skin Inflammation , 2014, The Journal of Immunology.
[309] R. Rabin,et al. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. , 1999, Journal of immunology.
[310] E. Kunkel,et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. , 2001, The Journal of clinical investigation.
[311] K. Jarnagin,et al. Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. , 1999, Biochemistry.
[312] P. Murphy,et al. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.
[313] Z. Prohászka,et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. , 2001, Atherosclerosis.
[314] R. Leibel,et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.
[315] H. Flad,et al. Identification of Distinct Surface-Expressed and Intracellular CXC-Chemokine Receptor 2 Glycoforms in Neutrophils: N-Glycosylation Is Essential for Maintenance of Receptor Surface Expression1 , 2000, The Journal of Immunology.
[316] I. Williams,et al. Absence of CCR6 inhibits CD4+ regulatory T-cell development and M-cell formation inside Peyer's patches. , 2005, The American journal of pathology.
[317] T. Kakiuchi,et al. Mice Lacking Expression of the Chemokines Ccl21-Ser and Ccl19 (plt Mice) Demonstrate Delayed but Enhanced T Cell Immune Responses , 2001, The Journal of experimental medicine.
[318] S. Shin,et al. Leukotactin‐1/CCL15‐induced chemotaxis signaling through CCR1 in HOS cells , 2002, FEBS letters.
[319] T. Meshel,et al. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner. , 2006, Cytokine.
[320] W. Wood,et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.
[321] C. Caux,et al. Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1 , 2000, The Journal of Immunology.
[322] S. Kelsen,et al. CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[323] Taoyong Chen,et al. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. , 2007, Molecular immunology.
[324] C. Mackay,et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.
[325] T. Baillie,et al. Pharmacokinetics and Interactions of a Novel Antagonist of Chemokine Receptor 5 (CCR5) with Ritonavir in Rats and Monkeys: Role of CYP3A and P-Glycoprotein , 2002, Journal of Pharmacology and Experimental Therapeutics.
[326] S. Rai,et al. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines , 2009, International journal of cancer.
[327] G. Lisignoli,et al. Human osteoblasts express functional CXC chemokine receptors 3 and 5: Activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and β‐N‐acetylhexosaminidase release , 2003, Journal of cellular physiology.
[328] L. Schweitzer,et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. , 1997, Journal of immunology.
[329] V. Viswanadhan,et al. A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease. , 2016, Journal of medicinal chemistry.
[330] M. Peck,et al. A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.
[331] F. Bäckhed,et al. Helicobacter pylori Infection Induces Interleukin-8 Receptor Expression in the Human Gastric Epithelium , 2003, Infection and Immunity.
[332] S. Lira,et al. CCR8 Is Expressed by Antigen-Elicited, IL-10-Producing CD4+CD25+ T Cells, Which Regulate Th2-Mediated Granuloma Formation in Mice1 , 2005, The Journal of Immunology.
[333] J. Farber,et al. Cloning of STRL22, a new human gene encoding a G-protein-coupled receptor related to chemokine receptors and located on chromosome 6q27. , 1997, Genomics.
[334] Samantha L. Hoopes,et al. Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development. , 2014, Developmental cell.
[335] Trixie Wagner,et al. Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo. , 2008, Journal of medicinal chemistry.
[336] E. Kremmer,et al. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. , 2011, Immunity.
[337] Yu Wang,et al. Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease , 2010, Journal of Pharmacology and Experimental Therapeutics.
[338] Meng-tse Wu,et al. CXCR5-Transduced Bone Marrow-Derived Dendritic Cells Traffic to B Cell Zones of Lymph Nodes and Modify Antigen-Specific Immune Responses , 2002, The Journal of Immunology.
[339] M. Parmentier,et al. The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. , 1996, Genomics.
[340] Sergio Romagnani,et al. An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 , 2003, The Journal of experimental medicine.
[341] R. Rudick,et al. Expression of CCR2, CCR5, and CXCR3 by CD4+ T cells is stable during a 2-year longitudinal study but varies widely between individuals , 2003, Journal of NeuroVirology.
[342] P. Gray,et al. Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.
[343] H. Heng,et al. Cloning of human genes encoding novel G protein-coupled receptors. , 1994, Genomics.
[344] K. Goralski,et al. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. , 2010, Endocrinology.
[345] J. Demartino,et al. Binding and Functional Properties of Recombinant and Endogenous CXCR3 Chemokine Receptors* , 1998, The Journal of Biological Chemistry.
[346] C. Weber,et al. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age , 2003, Journal of Molecular Medicine.
[347] C. E. Hudson,et al. Regulatory Effects of Eotaxin, Eotaxin-2, and Eotaxin-3 on Eosinophil Degranulation and Superoxide Anion Generation1 , 2002, Experimental biology and medicine.
[348] R. Hertzberg,et al. Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.
[349] J. Mikovits,et al. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. , 1999, Blood.
[350] A. Mangano,et al. Protective Effect of CCR2‐64I and Not of CCR5‐&Dgr;32 and SDF1‐3′A in Pediatric HIV‐1 Infection , 2000, Journal of acquired immune deficiency syndromes.
[351] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[352] D. Gray,et al. CCR7 Signals Are Essential for Cortex–Medulla Migration of Developing Thymocytes , 2004, The Journal of experimental medicine.
[353] R. Leurs,et al. β-Arrestin Recruitment and G Protein Signaling by the Atypical Human Chemokine Decoy Receptor CCX-CKR* , 2013, The Journal of Biological Chemistry.
[354] E. Nakayama,et al. Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6– and IL-8–Expressing Tumors through Predominant Induction of CXCR1 by IL-6 , 2010, The Journal of Immunology.
[355] N. Giese,et al. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma , 2012, International journal of cancer.
[356] R. Terkeltaub,et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.
[357] S. Opella,et al. Structure of the Chemokine Receptor CXCR1 in Phospholipid Bilayers , 2012, Nature.
[358] D. Figarella-Branger,et al. CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies , 2001, Acta Neuropathologica.
[359] C. Browning,et al. Signalling by CXC‐chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPγS binding induced by IL‐8 and GROα , 1999, British journal of pharmacology.
[360] Antonio Lanzavecchia,et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.
[361] E. Butcher,et al. Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades* , 2005, Journal of Biological Chemistry.
[362] M. Cristofanilli,et al. A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process , 2015, Translational oncology.
[363] J. Zapata,et al. Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma , 2013, Journal of Hematology & Oncology.
[364] A. Moschen,et al. Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2 , 2014, EMBO molecular medicine.
[365] C. Combadière,et al. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES , 1996, Journal of leukocyte biology.
[366] M. Baggiolini,et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.
[367] Xiangshan Yang,et al. The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas , 2014, Tumor Biology.
[368] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[369] M. Peitsch,et al. Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. , 1997, European journal of biochemistry.
[370] R. Rabin,et al. HIV-1 Tat protein mimicry of chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[371] J. Epplen,et al. Association of interleukin 8 receptor alpha polymorphisms with chronic obstructive pulmonary disease and asthma , 2005 .
[372] D. Waugh,et al. The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.
[373] I. Forbes,et al. CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach. , 2003, Journal of medicinal chemistry.
[374] J. Cyster,et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5 , 2004, Nature Immunology.
[375] Christopher S. Poss,et al. CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases* , 2003, Journal of Biological Chemistry.
[376] E. Kremmer,et al. Generalized multi‐organ autoimmunity in CCR7‐deficient mice , 2007, European journal of immunology.
[377] C. Cohen,et al. The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. , 2010, Kidney international.
[378] Zhidong Wang,et al. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell , 2016, Tumor Biology.
[379] H. Heng,et al. Isolation of three novel human genes encoding G protein-coupled receptors. , 1995, DNA and cell biology.
[380] J. Hoxie,et al. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. , 1998, Journal of immunology.
[381] T. Yoshimura,et al. Chemerin reveals its chimeric nature , 2008, The Journal of experimental medicine.
[382] I. Williams. Chemokine receptors and leukocyte trafficking in the mucosal immune system , 2004, Immunologic research.
[383] R. Geha,et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. , 2002, The Journal of clinical investigation.
[384] C. Lloyd,et al. CC Chemokine Ligand 1 Promotes Recruitment of Eosinophils But Not Th2 Cells During the Development of Allergic Airways Disease1 , 2003, The Journal of Immunology.
[385] B. Cullen,et al. Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor , 1997, The EMBO journal.
[386] E. García-Zepeda,et al. Janus kinase 3‐deficient T lymphocytes have an intrinsic defect in CCR7‐mediated homing to peripheral lymphoid organs , 2007, Immunology.
[387] K. Herrmann,et al. CXCR4 Ligands: The Next Big Hit? , 2017, The Journal of Nuclear Medicine.
[388] S. Coughlin,et al. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[389] T. Standiford,et al. Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2−/− Mice1 , 2000, The Journal of Immunology.
[390] G. Cao,et al. C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer , 2014, Tumor Biology.
[391] K. Welsh,et al. Correspondence and requests for reprints should be addressed to Dr. Martin , 2022 .
[392] D. Ribatti,et al. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. , 2000, Blood.
[393] O. Sansom,et al. CXCR2 inhibition suppresses acute and chronic pancreatic inflammation , 2015, The Journal of pathology.
[394] K. Matsuda,et al. Structure-activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists. , 2003, Bioorganic & medicinal chemistry.
[395] L. Caputi,et al. Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice , 2007, Journal of leukocyte biology.
[396] D M Merfeld,et al. Spatial orientation of VOR to combined vestibular stimuli in squirrel monkeys. , 1991, Acta oto-laryngologica. Supplementum.
[397] G. Gerosa,et al. Expression and functional activity of CXCR‐4 and CCR‐5 chemokine receptors in human thymocytes , 2002, Clinical and experimental immunology.
[398] Jeff F. Miller,et al. CXCR3 and Its Ligands Participate in the Host Response to Bordetella bronchiseptica Infection of the Mouse Respiratory Tract but Are Not Required for Clearance of Bacteria from the Lung , 2005, Infection and Immunity.
[399] T. Geiser,et al. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. , 1994, The Journal of biological chemistry.
[400] W. Greenlee,et al. Discovery of 4-[(Z)-(4-bromophenyl)- (ethoxyimino)methyl]-1'-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4'-methyl-1,4'- bipiperidine N-oxide (SCH 351125): an orally bioavailable human CCR5 antagonist for the treatment of HIV infection. , 2001, Journal of medicinal chemistry.
[401] X Zhang,et al. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. , 1998, Biochemical and biophysical research communications.
[402] Frank Diehl,et al. Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists , 2000, The Journal of Biological Chemistry.
[403] Sharon Engel,et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.
[404] Y. Bae,et al. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7 , 2012, Breast Cancer Research.
[405] W. Rostène,et al. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: Functional effect of MCP‐1/CCL2 on calcium mobilization in primary cultured neurons , 2005, The Journal of comparative neurology.
[406] C. Berek,et al. CXCR5‐deficient mice develop functional germinal centers in the splenic T cell zone , 2000, European journal of immunology.
[407] B. Miller,et al. The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects , 2015, BMC Pharmacology and Toxicology.
[408] S. Kelsen,et al. The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[409] R. Doms,et al. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999, Blood.
[410] I. Ghiran,et al. Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors , 2006, Stem cells.
[411] W. Hancock,et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. , 2000, The Journal of clinical investigation.
[412] M. Parmentier,et al. Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor , 1996, European journal of immunology.
[413] E. Bonifacio,et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. , 2012, The Journal of clinical investigation.
[414] J. R. White,et al. Ligand-induced Desensitization of the Human CXC Chemokine Receptor-2 Is Modulated by Multiple Serine Residues in the Carboxyl-terminal Domain of the Receptor* , 1997, The Journal of Biological Chemistry.
[415] A. Mantovani,et al. An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15 , 2015, British journal of pharmacology.
[416] W. Hickey,et al. CXC Chemokine Receptor-2 Ligands Are Required for Neutrophil-Mediated Host Defense in Experimental Brain Abscesses1 , 2001, The Journal of Immunology.
[417] Hiroaki Mitsuya,et al. Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5* , 2001, The Journal of Biological Chemistry.
[418] C. Thoburn,et al. Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations. , 2007, The Journal of investigative dermatology.
[419] M. Shi,et al. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation , 2015, Journal of Neuroinflammation.
[420] D. Salant,et al. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. , 1999, The Journal of clinical investigation.
[421] W. Han,et al. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4) , 2005, Life Sciences.
[422] W. Kuziel,et al. The CC Chemokine Receptor 5 Is Important in Control of Parasite Replication and Acute Cardiac Inflammation following Infection with Trypanosoma cruzi , 2006, Infection and Immunity.
[423] D. J. Nelson,et al. Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5. , 2015, ACS medicinal chemistry letters.
[424] H. Broxmeyer,et al. Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue , 1996, The Journal of experimental medicine.
[425] Y. Wan,et al. Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding. , 2002, European journal of pharmacology.
[426] Eric J Miller,et al. Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists. , 2018, ACS medicinal chemistry letters.
[427] P. Debré,et al. Two Novel Fully Functional Isoforms of CX3CR1 Are Potent HIV Coreceptors 1 , 2003, The Journal of Immunology.
[428] A. Foussat,et al. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. , 2000, Blood.
[429] R. Eddy,et al. Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2. , 1994, Genomics.
[430] S. Lira,et al. Impaired lung dendritic cell activation in CCR2 knockout mice. , 2004, The American journal of pathology.
[431] J. Cerhan,et al. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis , 2013, Cancer Immunology, Immunotherapy.
[432] B. Volkman,et al. Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. , 2015, Cytokine.
[433] R. Nibbs,et al. Characterization of mouse CCX‐CKR, a receptor for the lymphocyte‐attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP‐3β/mCCL19: comparison to human CCX‐CKR , 2002, European journal of immunology.
[434] N. Copeland,et al. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[435] H. Soto,et al. CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.
[436] A. Liptáková,et al. Genetic variations of interleukin‐8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children , 2012, International journal of immunogenetics.
[437] R. Eddy,et al. The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues. , 1995, Gene.
[438] I. Gorudko,et al. Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2. , 2002, Blood.
[439] P. Higgins,et al. Novel, Acidic CCR2 Receptor Antagonists: Lead Optimization , 2007 .
[440] W. Wood,et al. Characterization of two high affinity human interleukin-8 receptors. , 1992, The Journal of biological chemistry.
[441] S. Galli,et al. Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis , 2008, The Journal of experimental medicine.
[442] M. Baggiolini,et al. Identification of CCR8, the Receptor for the Human CC Chemokine I-309* , 1997, The Journal of Biological Chemistry.
[443] P. Murphy,et al. Cloning and Differential Tissue-specific Expression of Three Mouse Chemokine Receptor-like Genes, Including the Gene for a Functional Macrophage Inflammatory Protein-1 Receptor (*) , 1995, The Journal of Biological Chemistry.
[444] C. Martínez-A,et al. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. , 1997, The Journal of clinical investigation.
[445] A. Maghazachi,et al. MIP‐3α, MIP‐3β and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells , 1998, Immunology.
[446] P. Murphy,et al. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. , 1996, The Journal of biological chemistry.
[447] Fa-Yu Liu,et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. , 2014, International journal of oncology.
[448] R. Cholera,et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection , 2005, The Journal of experimental medicine.
[449] J. Serody,et al. Host Absence of CCR5 Potentiates Dendritic Cell Vaccination1 , 2003, The Journal of Immunology.
[450] R. Lehmann,et al. The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival , 2003, Development.
[451] J. Goedert,et al. Role of Exonic Variation in Chemokine Receptor Genes on AIDS: CCRL2 F167Y Association with Pneumocystis Pneumonia , 2011, PLoS genetics.
[452] Ji Ming Wang,et al. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. , 1998, European journal of biochemistry.
[453] C. Kleeberger,et al. CCR5 promoter polymorphism and HIV-1 disease progression , 1998, The Lancet.
[454] J. Cyster,et al. CC Chemokine Receptor 7 Contributes to Gi-Dependent T Cell Motility in the Lymph Node1 , 2007, The Journal of Immunology.
[455] N. Heveker,et al. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways , 2011, Proceedings of the National Academy of Sciences.
[456] E. Wolf,et al. A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen , 1996, Cell.
[457] T. Blankenstein,et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.
[458] Y. Kato,et al. Chemokines induce eosinophil degranulation through CCR-3. , 2000, The Journal of allergy and clinical immunology.
[459] H. Bourne,et al. Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[460] W. Rostène,et al. Characterization and visualization of [125I] stromal cell-derived factor-1α binding to CXCR4 receptors in rat brain and human neuroblastoma cells , 2000, Journal of Neuroimmunology.
[461] R. Doms,et al. Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8 , 2006, Molecular Pharmacology.
[462] A. Cuadrado,et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. , 2004, Blood.
[463] H. Broxmeyer,et al. Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.
[464] Yue Sun,et al. β-Arrestin2 Is Critically Involved in CXCR4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of p38 MAPK Activation* , 2002, The Journal of Biological Chemistry.
[465] N. Heveker,et al. AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties , 2009, Molecular Pharmacology.
[466] D. Nicholls,et al. Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist , 2015, The Journal of Pharmacology and Experimental Therapeutics.
[467] C. Dahinden,et al. Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists , 1999, European journal of immunology.
[468] A. Korman,et al. Nucleic acids encoding human monoclonal antibodies that bind CXCR4 , 2013 .
[469] M. McCrae,et al. Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine. , 2014, Vaccine.
[470] M. Dean,et al. Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes , 2004, Human Genomics.
[471] B. Rollins,et al. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection , 2004, Virology.
[472] S. Shore,et al. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[473] T. Williams,et al. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 , 2003, European journal of immunology.
[474] P. Dorr,et al. Molecular cloning and radioligand binding characterization of the chemokine receptor CCR5 from rhesus macaque and human. , 2005, Biochemical pharmacology.
[475] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[476] J. Drabek,et al. CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction. , 2003, Immunology letters.
[477] M. Thelen,et al. Complementary methods provide evidence for the expression of CXCR7 on human B cells , 2012, Proteomics.
[478] L. Kemény,et al. Interleukin‐8 receptor‐mediated chemotaxis of normal human epidermal cells , 1992, FEBS letters.
[479] K. Channon,et al. CXCR2 modulates bone marrow vascular repair and haematopoietic recovery post‐transplant , 2015, British journal of haematology.
[480] F. Baleux,et al. The CXCL12γ Chemokine Displays Unprecedented Structural and Functional Properties that Make It a Paradigm of Chemoattractant Proteins , 2008, PloS one.
[481] D. A. McGrath,et al. Pharmacological and signaling analysis of human chemokine receptor CCR-7 stably expressed in HEK-293 cells: high-affinity binding of recombinant ligands MIP-3beta and SLC stimulates multiple signaling cascades. , 1999, Biochemical and biophysical research communications.
[482] S. Dey,et al. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. , 2013, Cancer cell.
[483] Kuan-Teh Jeang,et al. Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.
[484] E. Butcher,et al. The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse1 , 2000, The Journal of Immunology.
[485] S. J. Myers,et al. Organization and Differential Expression of the Human Monocyte Chemoattractant Protein 1 Receptor Gene , 1997, The Journal of Biological Chemistry.
[486] H. Nomiyama,et al. Molecular Cloning of a Novel Human CC Chemokine (Eotaxin-3) That Is a Functional Ligand of CC Chemokine Receptor 3* , 1999, The Journal of Biological Chemistry.
[487] Á. Zaballos,et al. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. , 1999, Journal of immunology.
[488] S. McColl,et al. The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi. , 2013, Blood.
[489] Emili Montserrat,et al. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. , 2008, Cancer research.
[490] A. Mantovani,et al. Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3α from Lung Dendritic Cells , 1997, The Journal of experimental medicine.
[491] H. Tilg,et al. Increased Expression of CCL20 in Human Inflammatory Bowel Disease , 2004, Journal of Clinical Immunology.
[492] 嶋 高広. A novel lipopolysaccharide inducible C-C chemokine receptor related gene in murine macrophages , 1999 .
[493] M. Stone,et al. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells. , 2004, Cytokine.
[494] T. Schall,et al. Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands , 2009, The Journal of Immunology.
[495] B. Rollins,et al. Impairment in Postischemic Neovascularization in Mice Lacking the CXC Chemokine Receptor 3 , 2005, Circulation research.
[496] E. Butcher,et al. Expression, Regulation, and Function of Atypical Chemerin Receptor CCRL2 on Endothelial Cells , 2012, The Journal of Immunology.
[497] J. Flynn,et al. Mycobacterium tuberculosis in Chemokine Receptor 2-Deficient Mice: Influence of Dose on Disease Progression , 2002, Infection and Immunity.
[498] E. Kremmer,et al. Thymic T Cell Development and Progenitor Localization Depend on CCR7 , 2004, The Journal of experimental medicine.
[499] V. de Waard,et al. The presence of leukocyte CC-chemokine receptor 2 in CCR2 knockout mice promotes atherogenesis. , 2005, Biochimica et biophysica acta.
[500] B. Nardelli,et al. C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1 , 2000, The Journal of Immunology.
[501] T. Schwartz,et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. , 1997, Science.
[502] N. Bresolin,et al. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease. , 2004, Journal of the neurological sciences.
[503] A. Viola,et al. CXCR4 signaling in health and disease. , 2016, Immunology letters.
[504] Martin Schäfer,et al. Cloning of a novel putative G‐protein‐coupled receptor (NLR) which is expressed in neuronal and lymphatic tissue , 1993, FEBS letters.
[505] G. Murphy,et al. Molecular characterization of CXCR–4: A potential brain tumor‐associated gene , 1998, Journal of surgical oncology.
[506] S. Brand,et al. Increased Expression of the Chemokine Fractalkine in Crohn's Disease and Association of the Fractalkine Receptor T280M Polymorphism with a Fibrostenosing Disease Phenotype , 2006, The American Journal of Gastroenterology.
[507] R. Chakraborty,et al. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3′A, CCR2-64I, and CCR5-Δ32) in global populations , 2000, European Journal of Human Genetics.
[508] J. Zack,et al. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus , 1997, Journal of virology.
[509] J. Fantini,et al. Co‐expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT‐29 , 1997, AIDS.
[510] C. Martínez-A,et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. , 2001, The Journal of clinical investigation.
[511] H. Sarau,et al. Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. , 2000, Molecular pharmacology.
[512] S. Rees,et al. Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors , 2013, Journal of biomolecular screening.
[513] F. Ando,et al. Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density. , 2002, Genomics.
[514] Günter Bernhardt,et al. Cooperating Mechanisms of CXCR5 and CCR7 in Development and Organization of Secondary Lymphoid Organs , 2003, The Journal of experimental medicine.
[515] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[516] M. Kleinewietfeld,et al. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. , 2005, Blood.
[517] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[518] E. Pearlman,et al. CXC Chemokine Receptor 2 But Not C-C Chemokine Receptor 1 Expression Is Essential for Neutrophil Recruitment to the Cornea in Helminth-Mediated Keratitis (River Blindness)1 , 2001, The Journal of Immunology.
[519] R. Ransohoff,et al. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS , 2012, Journal of Neuroimmunology.
[520] Gregory R. Koch,et al. Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3 , 2005, Molecular Diversity.
[521] B. Baune,et al. Knockout of CXCR5 increases the population of immature neural cells and decreases proliferation in the hippocampal dentate gyrus , 2014, Journal of Neuroinflammation.
[522] M. Rocchi,et al. Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. , 1996, Journal of immunology.
[523] P. Herdewijn,et al. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. , 1997, Biochemistry.
[524] Dominique Schols,et al. Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication. , 2010, Journal of medicinal chemistry.
[525] M. Biondi,et al. Internal Carotid Artery Occlusive Disease and Polymorphisms of Fractalkine Receptor CX3CR1: A Genetic Risk Factor , 2004, Stroke.
[526] P. Gray,et al. CCR11 Is a Functional Receptor for the Monocyte Chemoattractant Protein Family of Chemokines* , 2000, The Journal of Biological Chemistry.
[527] K. Matsushima,et al. Preparation of specific polyclonal antibodies to a C-C chemokine receptor , CCR 1 , and determination of CCR 1 expression on various types of leukocytes , 2005 .
[528] D. Weissman,et al. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor , 1997, Nature.
[529] M. Smit,et al. Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice , 2005, European journal of immunology.
[530] A. Zaslaver,et al. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2. , 1999, Cytokine.
[531] L. Hang,et al. Interleukin 8 Receptor Deficiency Confers Susceptibility to Acute Experimental Pyelonephritis and May Have a Human Counterpart , 2000, The Journal of experimental medicine.
[532] N. Hosoe,et al. Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[533] Eric J Miller,et al. Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties. , 2018, Journal of medicinal chemistry.
[534] M. Dorf,et al. Alternate splicing of mouse fusin/CXC chemokine receptor-4: stromal cell-derived factor-1alpha is a ligand for both CXC chemokine receptor-4 isoforms. , 1997, Journal of immunology.
[535] CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. , 2002, The Journal of clinical investigation.
[536] Dongwei Kang,et al. Discovery of Non‐Peptide Small Molecular CXCR4 Antagonists as anti‐HIV Agents: Recent Advances and Future Opportunities , 2016 .
[537] C. Hogaboam,et al. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[538] N. Maeda,et al. Inflammatory Protein-1 Receptor ( CCR ) 5-, Macrophage in CC Chemokine Leishmania donovani Overcome to Control Infection with Are γ Defects in the Generation of IFN - , 1999 .
[539] A. Mantovani,et al. Identification of the CC chemokines TARC and macrophage inflammatory protein‐1β as novel functional ligands for the CCR8 receptor , 1998, European journal of immunology.
[540] L. Hang,et al. Transepithelial Neutrophil Migration Is CXCR1 Dependent In Vitro and Is Defective in IL-8 Receptor Knockout Mice1 , 2000, The Journal of Immunology.
[541] B. Jégou,et al. Study of the HIV-1 receptors CD4, CXCR4, CCR5 and CCR3 in the human and rat testis. , 2002, Molecular human reproduction.
[542] J. Chies,et al. Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease. , 2005, Tissue antigens.
[543] M. Hughes,et al. Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load. , 2005, The Journal of infectious diseases.
[544] M. Kaneko,et al. A Novel, Selective, and Orally Available Antagonist for CC Chemokine Receptor 3 , 2006, Journal of Pharmacology and Experimental Therapeutics.
[545] C. Combadière,et al. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. , 1998, The Journal of biological chemistry.
[546] F. Baleux,et al. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. , 2008, Blood.
[547] A. Gruber,et al. CXCR2 Regulates Respiratory Syncytial Virus-Induced Airway Hyperreactivity and Mucus Overproduction1 , 2003, The Journal of Immunology.
[548] Yasushi Tojo,et al. Structural and Molecular Interactions of CCR5 Inhibitors with CCR5* , 2006, Journal of Biological Chemistry.
[549] M. Dwyer,et al. Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist. , 2006, Journal of medicinal chemistry.
[550] H. Huang,et al. Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. , 2001, Biochemical and biophysical research communications.
[551] J. Xiang,et al. Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor1 , 2001, The Journal of Immunology.
[552] R. Horuk,et al. Chemokine receptor antagonists. , 2012, Journal of medicinal chemistry.
[553] U. V. von Andrian,et al. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo , 2007, The Journal of experimental medicine.
[554] O. Nishimura,et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[555] C. Combadière,et al. Cloning and functional expression of a human eosinophil CC chemokine receptor. , 1996, The Journal of biological chemistry.
[556] M. Karow,et al. The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia1 , 2005, The Journal of Immunology.
[557] J. Lindgren,et al. Decreased IgG production but increased MIP-1beta expression in collagen-induced arthritis in C-C chemokine receptor 5-deficient mice. , 2005, Cytokine.
[558] C. Combadière,et al. Cloning, chromosomal localization, and RNA expression of a human beta chemokine receptor-like gene. , 1995, DNA and cell biology.
[559] R. Wong,et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. , 2006, Biochemical pharmacology.
[560] H. Yamaue,et al. High CCR7 mRNA expression of cancer cells is associated with lymph node involvement in patients with esophageal squamous cell carcinoma. , 2009, International journal of oncology.
[561] H. Shin,et al. CXCR3 polymorphisms associated with risk of asthma. , 2005, Biochemical and biophysical research communications.
[562] J. R. White,et al. Impaired healing of nitrogen mustard wounds in CXCR2 null mice , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[563] Frédéric Pincet,et al. Enhanced Adhesive Capacities of the Naturally Occurring Ile249–Met280 Variant of the Chemokine Receptor CX3CR1* , 2004, Journal of Biological Chemistry.
[564] Y. Xia,et al. Identification of Two Rat Genes Orthologous to the Human Interleukin-8 Receptors* , 1996, The Journal of Biological Chemistry.
[565] J. Shively,et al. Evidence that cathelicidin peptide LL‐37 may act as a functional ligand for CXCR2 on human neutrophils , 2009, European journal of immunology.
[566] W. Gong,et al. Monocyte Chemotactic Protein-2 (MCP-2) Uses CCR1 AND CCR2B as Its Functional Receptors* , 1997, The Journal of Biological Chemistry.
[567] J. Barrish,et al. Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis. , 2014, Journal of medicinal chemistry.
[568] E. Butcher,et al. Chemoattractant Receptors and Lymphocyte Egress from Extralymphoid Tissue: Changing Requirements during the Course of Inflammation , 2009, The Journal of Immunology.
[569] J. Hoxie,et al. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors. , 1997, Blood.
[570] S. Lira,et al. Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.
[571] Michael Greenberg,et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4 , 1998, Current Biology.
[572] S. Bergeson,et al. Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol , 2005, Behavioural Brain Research.
[573] Axel Hoos,et al. Big opportunities for small molecules in immuno-oncology , 2015, Nature Reviews Drug Discovery.
[574] H. Acha‐Orbea,et al. CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. , 2002, Immunity.
[575] R. Duman,et al. Rat LCR1: cloning and cellular distribution of a putative chemokine receptor in brain. , 1996, Molecular psychiatry.
[576] H. Bourne,et al. Galphai is not required for chemotaxis mediated by Gi-coupled receptors. , 1999, The Journal of biological chemistry.
[577] I. Romero,et al. Regulation of chemokine receptor expression in human microglia and astrocytes , 2003, Journal of Neuroimmunology.
[578] R. Ferris,et al. Chemokine C Receptor 7 Expression and Protection of Circulating CD8+ T Lymphocytes from Apoptosis , 2005, Clinical Cancer Research.
[579] J. Ambati,et al. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. , 2003, Investigative ophthalmology & visual science.
[580] M. Westby,et al. CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection , 2005, Antiviral chemistry & chemotherapy.
[581] G Vassart,et al. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.
[582] Pietro Ghezzi,et al. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[583] D. Comings,et al. Association of CCR5 delta32 deletion with early death in multiple sclerosis. , 2004, Genetics in medicine : official journal of the American College of Medical Genetics.
[584] H. R. Lüttichau. The Cytomegalovirus UL146 Gene Product vCXCL1 Targets Both CXCR1 and CXCR2 as an Agonist* , 2009, The Journal of Biological Chemistry.
[585] M. Baggiolini,et al. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC , 2001, European journal of immunology.
[586] D. Sinnett,et al. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. , 2010, The Journal of biological chemistry.
[587] R. Miller,et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[588] S. Narula,et al. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. , 1999, Journal of immunology.
[589] I. Charo,et al. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. , 2003, The Journal of clinical investigation.
[590] D. Brown,et al. Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. , 2012, Bioorganic & medicinal chemistry letters.
[591] E. Butcher,et al. Cutting edge: developmental switches in chemokine responses during T cell maturation. , 1999, Journal of immunology.
[592] D. Teupser,et al. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[593] H. Pavenstädt,et al. Expression of Functional CCR and CXCR Chemokine Receptors in Podocytes1 , 2002, The Journal of Immunology.
[594] R. Strieter,et al. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. , 1999, Journal of immunology.
[595] L. Farkas,et al. Expression of CXC chemokine receptors 1 and 2 in human bronchial epithelial cells. , 2005, Chest.
[596] H. Brühl,et al. Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice1 , 2001, The Journal of Immunology.
[597] R. Suzuki,et al. Molecular cloning of mXCR1, the murine SCM‐1/lymphotactin receptor , 1999, FEBS letters.
[598] J. Ward,et al. Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells1 , 2001, The Journal of Immunology.
[599] M. Salmon,et al. Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5 , 2004, Arthritis research & therapy.
[600] T. Kurihara,et al. Cloning and Functional Expression of mCCR2, a Murine Receptor for the C-C Chemokines JE and FIC (*) , 1996, The Journal of Biological Chemistry.
[601] D. Rader,et al. Val64Ile Polymorphism in the C-C Chemokine Receptor 2 Is Associated With Reduced Coronary Artery Calcification , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[602] M. Burdick,et al. The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1 , 2000, The Journal of Immunology.
[603] F. Mayor,et al. Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation. , 2003, Molecular pharmacology.
[604] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[605] M. Schwarz,et al. Interfering with chemokine networks--the hope for new therapeutics. , 1999, Current opinion in chemical biology.
[606] U. Höpken,et al. Distinct and overlapping roles of CXCR5 and CCR7 in B‐1 cell homing and early immunity against bacterial pathogens , 2004, Journal of leukocyte biology.
[607] FrançoisCambien,et al. Adverse Associations Between CX3CR1 Polymorphisms and Risk of Cardiovascular or Cerebrovascular Disease , 2005 .
[608] G. Lisignoli,et al. Recruitment and proliferation of T lymphocytes is supported by IFNγ‐ and TNFα‐activated human osteoblasts: Involvement of CD54 (ICAM‐1) and CD106 (VCAM‐1) adhesion molecules and CXCR3 chemokine receptor , 2004, Journal of cellular physiology.
[609] M. Burger,et al. Human B cells express the orphan chemokine receptor CRAM‐A/B in a maturation‐stage‐dependent and CCL5‐modulated manner , 2008, Immunology.
[610] S. Sbrana,et al. Post‐reperfusion changes of monocyte function in coronary blood after extracorporeal circulation , 2005, Cytometry. Part B, Clinical cytometry.
[611] R. Förster,et al. The G protein‐coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues , 1993, European journal of immunology.
[612] D. Jeanfavre,et al. N-Arylsulfonyl-α-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity. , 2016, Bioorganic & medicinal chemistry letters.
[613] Andrew D. Luster,et al. Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function* , 2004, Journal of Biological Chemistry.
[614] F. Baleux,et al. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. , 2009, Blood.
[615] W. Kuziel,et al. CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.
[616] Jean-François Zagury,et al. Genome-wide association study implicates PARD3B-based AIDS restriction. , 2011, The Journal of infectious diseases.
[617] R. Strieter,et al. A critical role of CXCR2 PDZ-mediated interactions in endothelial progenitor cell homing and angiogenesis. , 2015, Stem cell research.
[618] M. Kronenberg,et al. Lack of Chemokine Receptor CCR5 Promotes Murine Fulminant Liver Failure by Preventing the Apoptosis of Activated CD1d-Restricted NKT Cells1 , 2005, The Journal of Immunology.
[619] C. Combadière,et al. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. , 1998, Biochemical and biophysical research communications.
[620] M. Raffeld,et al. Chromothriptic Cure of WHIM Syndrome , 2015, Cell.
[621] H. Nomiyama,et al. Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC* , 1997, The Journal of Biological Chemistry.
[622] I. Charo,et al. A Mechanism for the Impaired IFN-γ Production in C-C Chemokine Receptor 2 (CCR2) Knockout Mice: Role of CCR2 in Linking the Innate and Adaptive Immune Responses1 , 2000, The Journal of Immunology.
[623] Á. Zaballos,et al. Molecular cloning and RNA expression of two new human chemokine receptor-like genes. , 1996, Biochemical and biophysical research communications.
[624] E. Kremmer,et al. CC chemokine receptor 7 and 9 double-deficient hematopoietic progenitors are severely impaired in seeding the adult thymus. , 2010, Blood.
[625] H. Sung,et al. Differential CCR1‐mediated chemotaxis signaling induced by human CC chemokine HCC‐4/CCL16 in HOS cells , 2005, FEBS letters.
[626] J. Duncia,et al. CCR3 Antagonists: A Potential New Therapy for the Treatment of Asthma. Discovery and Structure—Activity Relationships. , 2002 .
[627] B. Springthorpe,et al. The discovery of CCR3/H1 dual antagonists with reduced hERG risk. , 2012, Bioorganic & medicinal chemistry letters.
[628] W. Kuziel,et al. Cc Chemokine Receptor (Ccr)2 Is Required for Langerhans Cell Migration and Localization of T Helper Cell Type 1 (Th1)-Inducing Dendritic Cells , 2000, The Journal of experimental medicine.
[629] P. Harrigan,et al. Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response , 2003, AIDS.
[630] Graeme Milligan,et al. The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities* , 2005, Journal of Biological Chemistry.
[631] W. Kuziel,et al. Reduced Macrophage Infiltration and Demyelination in Mice Lacking the Chemokine Receptor CCR5 Following Infection with a Neurotropic Coronavirus , 2001, Virology.
[632] S. Rees,et al. Development of a Homogeneous MAP Kinase Reporter Gene Screen for the Identification of Agonists and Antagonists at the CXCR1 Chemokine Receptor , 2001, Journal of biomolecular screening.
[633] E. Butcher,et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues , 2005, Nature Immunology.
[634] L. Hang,et al. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. , 2000, The Journal of infectious diseases.
[635] K. Pillarisetti,et al. Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant. , 1999, Journal of immunology.
[636] L. Boulet,et al. Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo‐controlled clinical trial , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[637] D. Absher,et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution , 2011, Nature Genetics.
[638] P. Askenase,et al. Basophil Responses to Chemokines Are Regulated by Both Sequential and Cooperative Receptor Signaling1 , 2000, The Journal of Immunology.
[639] A. Zuckermann,et al. A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia–reperfusion injury and inflammation after on‐pump coronary artery bypass graft surgery , 2015, Clinical and experimental immunology.
[640] J. Goedert,et al. Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection , 2003, AIDS.
[641] J. D. Benson,et al. Cloning of the mouse fusin gene, homologue to a human HIV-1 co-factor. , 1996, Journal of immunology.
[642] Martin A. Schwarz,et al. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL‐60 cells: antagonism of hCCR1 activation by MIP‐1β , 2002, British journal of pharmacology.
[643] M. Dean,et al. Characterisation of SNP haplotype structure in chemokine and chemokine receptor genes using CEPH pedigrees and statistical estimation , 2004, Human Genomics.
[644] W. Rostène,et al. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain , 2002, Journal of neurochemistry.
[645] W I Wood,et al. Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.
[646] Uwe Völker,et al. Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits , 2014, Nature Genetics.
[647] T. Giese,et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. , 2001, European journal of immunology.
[648] A. Lehuen,et al. Macrophages and β-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes , 2014, EMBO molecular medicine.
[649] James J. Campbell,et al. Human G Protein–Coupled Receptor Gpr-9-6/Cc Chemokine Receptor 9 Is Selectively Expressed on Intestinal Homing T Lymphocytes, Mucosal Lymphocytes, and Thymocytes and Is Required for Thymus-Expressed Chemokine–Mediated Chemotaxis , 1999, The Journal of experimental medicine.
[650] S. Tsai,et al. Serum BLC/CXCL13 Concentrations and Renal Expression of CXCL13/CXCR5 in Patients with Systemic Lupus Erythematosus and Lupus Nephritis , 2010, The Journal of Rheumatology.
[651] D. Taub,et al. Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor* , 1998, The Journal of Biological Chemistry.